|
|
總筆數:55
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Low-molecular-weight heparin therapy for non-ST-elevation acute coronarysyndromes and during percutaneous coronary intervention: An expertconsensus^* |
Kereiakes, D.J.;Montalescot, G.;Antman, E.M.;Cohen, M.;Darius, H.;Ferguson, J.J.;Grines, C.;Karsch, K.R.;Kleiman, N.S.;Moliterno, D.J.;Steg, P.-G.;Teirstein, P.;Van de Werf, F.;Wallentin, L.; |
American Heart Journal |
2002-10-01 |
查看 |
| Low-molecular-weight heparin therapy for non-ST-elevation acutecoronary syndromes and during percutaneous coronary intervention: An expertconsensus^* |
Kereiakes, D.J.;Montalescot, G.;Antman, E.M.;Cohen, M.;Darius, H.;Ferguson, J.J.;Grines, C.;Karsch, K.R.;Kleiman, N.S.;Moliterno, D.J.;Steg, P.G.;Teirstein, P.;Van de Werf, F.;Wallentin, L.; |
American Heart Journal |
2002-10-01 |
查看 |
| Improved clinical outcomes with abciximab therapy in acute myocardialinfarction: a systematic overview of randomized clinical trials |
Kandzari, D.E.;Hasselblad, V.;Tcheng, J.E.;Stone, G.W.;Califf, R.M.;Kastrati, A.;Neumann, F.-J.;Brener, S.J.;Montalescot, G.;Kong, D.F.;Harrington, R.A.; |
American Heart Journal |
2004-03-01 |
查看 |
| Subcutaneous enoxaparin with early invasive strategy in patients with acutecoronary syndromes |
Collet, J.P.;Montalescot, G.;Golmard, J.L.;Tanguy, M.L.;Ankri, A.;Choussat, R.;Beygui, F.;Drobinski, G.;Vignolles, N.;Thomas, D.; |
American Heart Journal |
2004-04-01 |
查看 |
| Facilitated percutaneous coronary intervention versus primary percutaneouscoronary intervention: design and rationale of the facilitated interventionwith enhanced reperfusion speed to stop events (FINESSE) trial |
Ellis, S.G.;Armstrong, P.;Betriu, A.;Brodie, B.;Herrmann, H.;Montalescot, G.;Neumann, F.-J.;Smith, J.J.;Topol, E.;FINESSE Investigators; |
American Heart Journal |
2004-04-01 |
查看 |
| Subcutaneous enoxaparin with early invasive strategy in patients with acutecoronary syndromes |
Collet, J.P.;Montalescot, G.;Golmard, J.L.;Tanguy, M.L.;Ankri, A.;Choussat, R.;Beygui, F.;Drobinski, G.;Vignolles, N.;Thomas, D.; |
American Heart Journal |
2004-04-01 |
查看 |
| Facilitated percutaneous coronary intervention versus primary percutaneouscoronary intervention: design and rationale of the facilitated interventionwith enhanced reperfusion speed to stop events (FINESSE) trial |
Ellis, S.G.;Armstrong, P.;Betriu, A.;Brodie, B.;Herrmann, H.;Montalescot, G.;Neumann, F.-J.;Smith, J.J.;Topol, E.;FINESSE Investigators; |
American Heart Journal |
2004-04-01 |
查看 |
| Subcutaneous enoxaparin with early invasive strategy in patients withacute coronary syndromes |
Collet, J.;Montalescot, G.;Golmard, J.;Tanguy, M.;Ankri, A.;Choussat, R.;Beygui, F.;Drobinski, G.;Vignolles, N.;Thomas, D.; |
American Heart Journal |
2004-04-01 |
查看 |
| Facilitated percutaneous coronary intervention versus primarypercutaneous coronary intervention: design and rationale of the facilitatedintervention with enhanced reperfusion speed to stop events (FINESSE) trial |
FINESSE Investigators;Ellis, S.G.;Armstrong, P.;Betriu, A.;Brodie, B.;Herrmann, H.;Montalescot, G.;Neumann, F.J.;Smith, J.J.;Topol, E.; |
American Heart Journal |
2004-04-01 |
查看 |
| Impact of age on management and outcome of acute coronary syndrome:bservations from the Global Registry of Acute Coronary Events (GRACE) |
Avezum, A.;Makdisse, M.;Spencer, F.;Gore, J.M.;Fox, K.A.A.;Montalescot, G.;Eagle, K.A.;White, K.;Mehta, R.H.;Knobel, E.;Philippe Collet, J.-;for the GRACE Investigators; |
American Heart Journal |
2005-01-01 |
查看 |
| Impact of age on management and outcome of acute coronary syndrome:Observations from the global registry of acute coronary events (GRACE) |
Avezum, A.;Makdisse, M.;Spencer, F.;Gore, J.M.;Fox, K.A.A.;Montalescot, G.;Eagle, K.A.;White, K.;Mehta, R.H.;Knobel, E.;Philippe Collet, J.-;for the GRACE Investigators; |
American Heart Journal |
2005-01-01 |
查看 |
| Impact of age on management and outcome of acute coronary syndrome:Observations from the global registry of acute coronary events (GRACE) |
Avezum, A.;Makdisse, M.;Spencer, F.;Gore, J.M.;Fox, K.A.A.;Montalescot, G.;Eagle, K.A.;White, K.;Mehta, R.H.;Knobel, E.;Philippe Collet, J.-;for the GRACE Investigators; |
American Heart Journal |
2005-01-01 |
查看 |
| Impact of age on management and outcome of acute coronary syndrome:Observations from the global registry of acute coronary events (GRACE) |
Avezum, A.;Makdisse, M.;Spencer, F.;Gore, J.M.;Fox, K.A.A.;Montalescot, G.;Eagle, K.A.;White, K.;Mehta, R.H.;Knobel, E.;Philippe Collet, J.;for the GRACE Investigators; |
American Heart Journal |
2005-01-01 |
查看 |
| The Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment ElevationAcute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlledtrial evaluating the clinical benefits of early front-loaded eptifibatidein the treatment of patients with non-ST-segment elevation acute coronarysyndrome-Study design and rationale |
on behalf of the EARLY ACS Steering Committee;Giugliano, R.P.;Newby, L.K.;Harrington, R.A.;Gibson, C.M.;Van de Werf, F.;Armstrong, P.;Montalescot, G.;Gilbert, J.;Strony, J.T.;Califf, R.M.;Braunwald, E.; |
American Heart Journal |
2005-06-01 |
查看 |
| The Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment ElevationAcute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlledtrial evaluating the clinical benefits of early front-loaded eptifibatidein the treatment of patients with non-ST-segment elevation acute coronarysyndrome-Study design and rationale |
on behalf of the EARLY ACS Steering Committee;Giugliano, R.P.;Newby, L.K.;Harrington, R.A.;Gibson, C.M.;Van de Werf, F.;Armstrong, P.;Montalescot, G.;Gilbert, J.;Strony, J.T.;Califf, R.M.;Braunwald, E.; |
American Heart Journal |
2005-06-01 |
查看 |
| A global view of atherothrombosis: Baseline characteristics in theClopidogrel for High Atherothrombotic Risk and Ischemic Stabilization,Management, and Avoidance (CHARISMA) trial |
on behalf of the CHARISMA Investigators;Bhatt, D.L.;Fox, K.A.;Hacke, W.;Berger, P.B.;Black, H.R.;Boden, W.E.;Cacoub, P.;Cohen, E.A.;Creager, M.A.;Easton, J.D.;Flather, M.D.;Haffner, S.M.;Hamm, C.W.;Hankey, G.J.;Johnston, S.C.;Mak, K.H.;Mas, J.L.;Montalescot, G.;Pearson, T.A.;Steg, P.G.;Steinhubl, S.R.;Weber, M.A.;Booth, J.;Topol, E.J.; |
American Heart Journal |
2005-09-01 |
查看 |
| A global view of atherothrombosis: Baseline characteristics in theClopidogrel for High Atherothrombotic Risk and Ischemic Stabilization,Management, and Avoidance (CHARISMA) trial |
on behalf of the CHARISMA Investigators;Bhatt, D.L.;Fox, K.A.;Hacke, W.;Berger, P.B.;Black, H.R.;Boden, W.E.;Cacoub, P.;Cohen, E.A.;Creager, M.A.;Easton, J.D.;Flather, M.D.;Haffner, S.M.;Hamm, C.W.;Hankey, G.J.;Johnston, S.C.;Mak, K.H.;Mas, J.L.;Montalescot, G.;Pearson, T.A.;Steg, P.G.;Steinhubl, S.R.;Weber, M.A.;Booth, J.;Topol, E.J.; |
American Heart Journal |
2005-09-01 |
查看 |
| A global view of atherothrombosis: Baseline characteristics in theClopidogrel for High Atherothrombotic Risk and Ischemic Stabilization,Management, and Avoidance (CHARISMA) trial |
on behalf of the CHARISMA Investigators;Bhatt, D.L.;Fox, K.A.;Hacke, W.;Berger, P.B.;Black, H.R.;Boden, W.E.;Cacoub, P.;Cohen, E.A.;Creager, M.A.;Easton, J.D.;Flather, M.D.;Haffner, S.M.;Hamm, C.W.;Hankey, G.J.;Johnston, S.C.;Mak, K.H.;Mas, J.L.;Montalescot, G.;Pearson, T.A.;Steg, P.G.;Steinhubl, S.R.;Weber, M.A.;Booth, J.;Topol, E.J.; |
American Heart Journal |
2005-09-01 |
查看 |
| Early versus periprocedural administration of abciximab for primaryangioplasty: A pooled analysis of 6 studies |
Godicke, J.;Flather, M.;Noc, M.;Gyongyosi, M.;Arntz, H.R.;Grip, L.;Gabriel, H.M.;Huber, K.;Nugara, F.;Schroder, J.;Svensson, L.;Wang, D.;Zorman, S.;Montalescot, G.; |
American Heart Journal |
2005-11-01 |
查看 |
| Early versus periprocedural administration of abciximab for primaryangioplasty: A pooled analysis of 6 studies |
Godicke, J.;Flather, M.;Noc, M.;Gyongyosi, M.;Arntz, H.R.;Grip, L.;Gabriel, H.M.;Huber, K.;Nugara, F.;Schroder, J.;Svensson, L.;Wang, D.;Zorman, S.;Montalescot, G.; |
American Heart Journal |
2005-11-01 |
查看 |
| Early versus periprocedural administration of abciximab for primaryangioplasty: A pooled analysis of 6 studies |
Godicke, J.;Flather, M.;Noc, M.;Gyongyosi, M.;Arntz, H.R.;Grip, L.;Gabriel, H.M.;Huber, K.;Nugara, F.;Schroder, J.;Svensson, L.;Wang, D.;Zorman, S.;Montalescot, G.; |
American Heart Journal |
2005-11-01 |
查看 |
| The diagnostic and prognostic impact of the redefinition of acutemyocardial infarction: Lessons from the Global Registry of Acute CoronaryEvents (GRACE) |
for the GRACE Investigators;Goodman, S.G.;Steg, P.G.;Eagle, K.A.;Fox, K.A.A.;Lopez-Sendon, J.;Montalescot, G.;Budaj, A.;Kennelly, B.M.;Gore, J.M.;Allegrone, J.;Granger, C.B.;Gurfinkel, E.P.; |
American Heart Journal |
2006-03-01 |
查看 |
| The diagnostic and prognostic impact of the redefinition of acutemyocardial infarction: Lessons from the Global Registry of Acute CoronaryEvents (GRACE) |
for the GRACE Investigators;Goodman, S.G.;Steg, P.G.;Eagle, K.A.;Fox, K.A.A.;Lopez-Sendon, J.;Montalescot, G.;Budaj, A.;Kennelly, B.M.;Gore, J.M.;Allegrone, J.;Granger, C.B.;Gurfinkel, E.P.; |
American Heart Journal |
2006-03-01 |
查看 |
| The diagnostic and prognostic impact of the redefinition of acutemyocardial infarction: Lessons from the Global Registry of Acute CoronaryEvents (GRACE) |
for the GRACE Investigators;Goodman, S.G.;Steg, P.G.;Eagle, K.A.;Fox, K.A.A.;Lopez-Sendon, J.;Montalescot, G.;Budaj, A.;Kennelly, B.M.;Gore, J.M.;Allegrone, J.;Granger, C.B.;Gurfinkel, E.P.; |
American Heart Journal |
2006-03-01 |
查看 |
| The diagnostic and prognostic impact of the redefinition of acutemyocardial infarction: Lessons from the Global Registry of Acute CoronaryEvents (GRACE) |
for the GRACE Investigators;Goodman, S.G.;Steg, P.G.;Eagle, K.A.;Fox, K.A.A.;Lopez-Sendon, J.;Montalescot, G.;Budaj, A.;Kennelly, B.M.;Gore, J.M.;Allegrone, J.;Granger, C.B.;Gurfinkel, E.P.; |
American Heart Journal |
2006-03-01 |
查看 |
| Evaluation of prasugrel compared with clopidogrel in patients withacute coronary syndromes: design and rationale for the TRial to assessImprovement in Therapeutic Outcomes by optimizing platelet InhibitioN withprasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38) |
for the TRITON-TIMI 38 Investigators;Wiviott, S.D.;Antman, E.M.;Gibson, C.M.;Montalescot, G.;Riesmeyer, J.;Weerakkody, G.;Winters, K.J.;Warmke, J.W.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2006-10-01 |
查看 |
| Evaluation of prasugrel compared with clopidogrel in patients withacute coronary syndromes: design and rationale for the TRial to assessImprovement in Therapeutic Outcomes by optimizing platelet InhibitioN withprasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38) |
for the TRITON-TIMI 38 Investigators;Wiviott, S.D.;Antman, E.M.;Gibson, C.M.;Montalescot, G.;Riesmeyer, J.;Weerakkody, G.;Winters, K.J.;Warmke, J.W.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2006-10-01 |
查看 |
| Interactions between heparins, glycoprotein IIb/IIIa antagonists, andcoronary intervention. The Global Registry of Acute Coronary Events (GRACE) |
for the GRACE Investigators;Brieger, D.;Van de Werf, F.;Avezum, A.;Montalescot, G.;Kennelly, B.M.;Granger, C.B.;Goodman, S.G.;Dabbous, O.H.;Agnelli, G.; |
American Heart Journal |
2007-06-01 |
查看 |
| Renal function, atherothrombosis extent, and outcomes in high-riskpatients |
on behalf of the REACH Registry Investigators;Dumaine, R.L.;Montalescot, G.;Steg, Ph.G.;Ohman, E.M.;Eagle, K.;Bhatt, D.L.; |
American Heart Journal |
2009-07-01 |
查看 |
| Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors innon-ST-elevation acute coronary syndrome patients: The Canadian GlobalRegistry of Acute Coronary Events (GRACE) experience |
for Global Registry of Acute Coronary Events (GRACE/GRACE^2);Investigators;Banihashemi, B.;Goodman, S.G.;Yan, R.T.;Welsh, R.C.;Mehta, S.R.;Montalescot, G.;Kornder, J.M.;Wong, G.C.;Gyenes, G.;Steg, Ph.G.;Yan, A.T.; |
American Heart Journal |
2009-12-01 |
查看 |
| Hematomas of at least 5 cm and outcomes in patients undergoing electivepercutaneous coronary intervention: Insights from the SafeTy and Efficacyof Enoxaparin in PCI patients, an internationaL randomized Evaluation(STEEPLE) trial |
for the STEEPLE Investigators;White, H.D.;Aylward, P.E.;Gallo, R.;Bode, C.;Steg, G.;Steinhubl, S.R.;Montalescot, G.; |
American Heart Journal |
2010-01-01 |
查看 |
| Ischemia-modified albumin levels predict long-term outcome in patientswith acute myocardial infarction. The French Nationwide OPERA study |
on behalf of The OPERA Investigators;Van Belle, E.;Dallongeville, J.;Vicaut, E.;Degrandsart, A.;Baulac, C.;Montalescot, G.; |
American Heart Journal |
2010-04-01 |
查看 |
| Rationale for an early aldosterone blockade in acute myocardialinfarction and design of the ALBATROSS trial |
Beygui, F.;Vicaut, E.;Ecollan, P.;Machecourt, J.;Van Belle, E.;Zannad, F.;Montalescot, G.; |
American Heart Journal |
2010-10-01 |
查看 |
| Rationale for an early aldosterone blockade in acute myocardialinfarction and design of the ALBATROSS trial |
Beygui, F.;Vicaut, E.;Ecollan, P.;Machecourt, J.;Van Belle, E.;Zannad, F.;Montalescot, G.; |
American Heart Journal |
2010-10-01 |
查看 |
| Association between smoking, outcomes, and early clopidogrel use inpatients with acute coronary syndrome: Insights from the Global Registry ofAcute Coronary Events |
Sibbald, M.;Yan, A.T.;Huang, W.;Fox, K.A.A.;Gore, J.M.;Steg, Ph.G.;Eagle, K.A.;Brieger, D.;Montalescot, G.;Goodman, S.G.; |
American Heart Journal |
2010-11-01 |
查看 |
| Randomized comparison of platelet function monitoring to adjustantiplatelet therapy versus standard of care: Rationale and design of theAssessment with a double Randomization of (1) a fixed dose versus amonitoring-guided dose of aspirin and Clopidogrel after DES implantation,and (2) Treatment Interruption versus Continuation, 1 year after stenting(ARCTIC) study |
Collet, J.P.;Cayla, G.;Cuisset, T.;Elhadad, S.;Range, G.;Vicaut, E.;Montalescot, G.; |
American Heart Journal |
2011-01-01 |
查看 |
| A randomized, partially blinded, multicenter, active-controlled,dose-ranging study assessing the safety, efficacy, and pharmacodynamics ofthe REG1 anticoagulation system in patients with acute coronary syndromes:Design and rationale of the RADAR Phase IIb trial |
Povsic, T.J.;Cohen, M.G.;Mehran, R.;Buller, C.E.;Bode, C.;Cornel, J.H.;Kasprzak, J.D.;Montalescot, G.;Joseph, D.;Wargin, W.A.;Rusconi, C.P.;Zelenkofske, S.L.;Becker, R.C.;Alexander, J.H.; |
American Heart Journal |
2011-02-01 |
查看 |
| A Comparison of prasugrel at the time of percutaneous Coronaryintervention or as pretreatment at the time of diagnosis in patients withnon-ST-segment elevation myocardial infarction: Design and rationale forthe ACCOAST study |
Montalescot, G.;Bolognese, L.;Dudek, D.;Goldstein, P.;Hamm, C.;Tanguay, J.F.;ten Berg, J.;Widimsky, P.;Luo, J.;Miller, D.L.;Goedicke, J.; |
American Heart Journal |
2011-04-01 |
查看 |
| Bleeding, mortality, and antiplatelet therapy: Results from theClopidogrel for High Atherothrombotic Risk and Ischemic Stabilization,Management, and Avoidance (CHARISMA) trial |
Berger, J.S.;Bhatt, D.L.;Steg, P.G.;Steinhubl, S.R.;Montalescot, G.;Shao, M.;Hacke, W.;Fox, K.A.;Berger, P.B.;Topol, E.J.;Lincoff, A.M.; |
American Heart Journal |
2011-07-01 |
查看 |
| Measuring and targeting aldosterone and renin in atherosclerosis-Areview of clinical data |
Hillaert, M.A.;Lentjes, E.G.;Beygui, F.;Kemperman, H.;Asselbergs, F.W.;Nathoe, H.M.;Agostoni, P.;Voskuil, M.;Ivanes, F.;Jude, B.;Bertrand, M.E.;Pasterkamp, G.;van der Graaf, Y.;Doevendans, P.A.;Montalescot, G.;Van Belle, E.; |
American Heart Journal |
2011-10-01 |
查看 |
| Safety and efficacy of adjusted-dose eptifibatide in patients withacute coronary syndromes and reduced renal function |
Melloni, C.;James, S.K.;White, J.A.;Giugliano, R.P.;Harrington, R.A.;Huber, K.;Tricoci, P.;Armstrong, P.W.;Van de Werf, F.;Montalescot, G.;Califf, R.M.;Newby, L.K.; |
American Heart Journal |
2011-11-01 |
查看 |
| Safety and efficacy of adjusted-dose eptifibatide in patients withacute coronary syndromes and reduced renal function |
Melloni, C.;James, S.K.;White, J.A.;Giugliano, R.P.;Harrington, R.A.;Huber, K.;Tricoci, P.;Armstrong, P.W.;Van de Werf, F.;Montalescot, G.;Califf, R.M.;Newby, L.K.; |
American Heart Journal |
2011-11-01 |
查看 |
| Ambulance or in-catheterization laboratory administration of ticagrelorfor primary percutaneous coronary intervention for ST-segment elevationmyocardial infarction: Rationale and design of the randomized, double-blindAdministration of Ticagrelor in the cath Lab or in the Ambulance for New STelevation myocardial Infarction to open the Coronary artery (ATLANTIC) study |
Montalescot, G.;Lassen, J.F.;Hamm, C.W.;Lapostolle, F.;Silvain, J.;ten Berg, J.M.;Cantor, W.J.;Goodman, S.G.;Licour, M.;Tsatsaris, A.;van't Hof, A.W.; |
American Heart Journal |
2013-04-01 |
查看 |
| Routine early eptifibatide versus delayed provisional use atpercutaneous coronary intervention in high-risk non-ST-segment elevationacute coronary syndromes patients: An analysis from the Early GlycoproteinIIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrometrial |
Bagai, A.;White, J.A.;Lokhnygina, Y.;Giugliano, R.P.;Van de Werf, F.;Montalescot, G.;Armstrong, P.W.;Tricoci, P.;Gibson, C.M.;Califf, R.M.;Harrington, R.A.;Newby, L.K.; |
American Heart Journal |
2013-09-01 |
查看 |
| Routine early eptifibatide versus delayed provisional use atpercutaneous coronary intervention in high-risk non-ST-segment elevationacute coronary syndromes patients: An analysis from the Early GlycoproteinIIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrometrial |
Bagai, A.;White, J.A.;Lokhnygina, Y.;Giugliano, R.P.;Van de Werf, F.;Montalescot, G.;Armstrong, P.W.;Tricoci, P.;Gibson, C.M.;Califf, R.M.;Harrington, R.A.;Newby, L.K.; |
American Heart Journal |
2013-09-01 |
查看 |
| Use of ranolazine in patients with incomplete revascularization afterpercutaneous coronary intervention: Design and rationale of the Ranolazinefor Incomplete Vessel Revascularization Post-Percutaneous CoronaryIntervention (RIVER-PCI) trial |
Weisz, G.;Farzaneh-Far, R.;Ben-Yehuda, O.;DeBruyne, B.;Montalescot, G.;Lerman, A.;Mahmud, E.;Alexander, K.P.;Ohman, E.M.;White, H.D.;Olmsted, A.;Walker, G.A.;Stone, G.W.; |
American Heart Journal |
2013-12-01 |
查看 |
| APPOSITION V: STENTYS coronary stent system clinical trial in subjectswith ST-segment elevation myocardial infarction-Rationale and design |
Grundeken, M.J.;Lu, H.;Mehran, R.;Cutlip, D.E.;Leon, M.B.;Yeung, A.;Koch, K.T.;Montalescot, G.;van Geuns, R.J.;Spaargaren, R.;Buchbinder, M.; |
American Heart Journal |
2014-11-01 |
查看 |
| Platelet function monitoring in elderly patients on prasugrel afterstenting for an acute coronary syndrome: Design of the randomized antarcticstudy |
for the ANTARCTIC investigators;Cayla, G.;Cuisset, T.;Silvain, J.;Henry, P.;Leclercq, F.;Carrie, D.;Etienne, C.S.;Belle, L.;Range, G.;Pouillot, C.;Varenne, O.;Van Belle, E.;Boueri, Z.;Motreff, P.;Elhadad, S.;Delarche, N.;El Mahmoud, R.;Vicaut, E.;Collet, J.P.;Montalescot, G.; |
American Heart Journal |
2014-11-01 |
查看 |
| APPOSITION V: STENTYS coronary stent system clinical trial in subjectswith ST-segment elevation myocardial infarction-Rationale and design |
Grundeken, M.J.;Lu, H.;Mehran, R.;Cutlip, D.E.;Leon, M.B.;Yeung, A.;Koch, K.T.;Montalescot, G.;van Geuns, R.J.;Spaargaren, R.;Buchbinder, M.; |
American Heart Journal |
2014-11-01 |
查看 |
| Platelet function monitoring in elderly patients on prasugrel afterstenting for an acute coronary syndrome: Design of the randomized antarcticstudy |
ANTARCTIC investigators;Cayla, G.;Cuisset, T.;Silvain, J.;Henry, P.;Leclercq, F.;Carrie, D.;Etienne, C.S.;Belle, L.;Range, G.;Pouillot, C.;Varenne, O.;Van Belle, E.;Boueri, Z.;Motreff, P.;Elhadad, S.;Delarche, N.;El Mahmoud, R.;Vicaut, E.;Collet, J.P.;Montalescot, G.; |
American Heart Journal |
2014-11-01 |
查看 |
| Incidence and consequence of major bleeding in primary percutaneousintervention for ST-elevation myocardial infarction in the era of radialaccess: an analysis of the international randomized Acute myocardialinfarction Treated with primary angioplasty and intravenous enoxaparin Orunfractionated heparin to Lower ischemic and bleeding events at short- andLong-term follow-up trial |
ATOLL Investigators;Pellaton, C.;Cayla, G.;Silvain, J.;Zeymer, U.;Cohen, M.;Goldstein, P.;Huber, K.;Pollack, C.;Kerneis, M.;Collet, J.P.;Vicaut, E.;Montalescot, G.; |
American Heart Journal |
2015-10-01 |
查看 |
| Impact of prasugrel pretreatment and timing of coronary artery bypassgrafting on clinical outcomes of patients with non-ST-segment elevationmyocardial infarction: From the A Comparison of Prasugrel at PCI or Time ofDiagnosis of Non-ST-Elevation Myocardial Infarction (ACCOAST) study |
ACCOAST Investigators;Dudek, D.;Dziewierz, A.;Widimsky, P.;Bolognese, L.;Goldstein, P.;Hamm, C.;Tanguay, J.F.;LeNarz, L.;Miller, D.L.;Brown, E.;ten Berg, J.;Montalescot, G.; |
American Heart Journal |
2015-11-01 |
查看 |
|
|
|
